CA 15-3/Cancer Antigen (CA -15-3)
Report in 12 hours
Booked 8 times
CA 15-3/Cancer Antigen (CA -15-3)

Cancer Antigen 15-3 (Breast Cancer Marker)

The Ibn Sina Trust
Praava Health
Dr Lal PathLabs
Omnicare Diagnostic Limited
Thyrocare Bangladesh Ltd
Brac Healthcare
Popular Diagnostic Centre Ltd
Ascent Health Limited
JG Healthcare
DNA Solution Ltd
Probe Bangladesh Limited
1120
1400
20% OFF
Sample Type
blood
Fasting Required
No
Description

CA 15-3 is considered a tumor marker because high levels of the antigen may indicate certain cancers, including breast cancer. CA 15-3 tests aren’t used to diagnose cancer, but rather to assess how cancer is responding to treatment. CA 15-3 fluctuations help cancer doctors determine whether a tumor is stable, growing, shrinking or has recurred.

Covid Safety

Assured

Free Report

Counselling

How our test process works!

Step 1

Sample Collection

Vaccinated Phlebotomists collects from syringe in the barcoded vials

Step 2

Sample Storage

Only vaccinated phelbos are assigned orders

Step 3

High Tech Facility

Lab ingests the sample into processing machines which are 100% automated

Step 4

Accurate Digital Reports

The reports are generated by the processing machines and clinically correlated by doctors

Overview

CA 15-3 is a tumor marker test mainly used to monitor breast cancer progression or response to treatment. It measures the amount of cancer antigen 15-3, a protein released into the blood by breast cancer cells.

Risk assessment

Risk Assessment / Purpose:

  • Helps in monitoring breast cancer treatment effectiveness.

  • Detects recurrence or metastasis of breast cancer.

  • Sometimes used to support diagnosis of other cancers (e.g., ovarian, lung, or pancreatic) though less specific.

Ranges

Normal Range:

  • Typically < 30 U/mL (may vary slightly by lab).

Test result interpretation

Interpretation:

  • High CA 15-3 levels may indicate:

    • Advanced or metastatic breast cancer

    • Other cancers (lung, ovarian, pancreatic, liver)

    • Non-cancerous conditions (liver disease, benign breast disorders, endometriosis)

  • Normal or low levels do not rule out early-stage cancer, as CA 15-3 may remain normal initially.

  • Changes over time are more important than a single result.

 

Sample types

Sample Type:

  • Venous blood sample (serum)

 

Frequently Asked Question